In addition , we set up two double-blind placebo controlled clinical trials with MPH in 50 boys ( 10-12 years ) and 50 young men ( 23-40 years ) suffering from ADHD ( ePOD-MPH ) and with FLX in 40 girls ( 12-14 years ) and 40 young women ( 23-40 years ) suffering from depression and anxiety disorders ( ePOD-SSRI ) .